(1) You must make immediately available a confidential post-exposure evaluation and follow-up to all employees with occupational exposure to blood or OPIM who report an exposure incident.

(2) You must make sure that the post-exposure medical evaluation and follow-up are all of the following:

(a) Immediately available following an exposure incident;

(b) Confidential;

(d) At a reasonable time and place;

(e) Administered by or under the supervision of a licensed physician or by another licensed health care professional;

(f) Provided according to recommendations of the United States Public Health Service current at the time these evaluations and procedures take place.

(3) You must make sure that the evaluation and follow-up includes at least these elements:

(a) Documentation of the routes of exposure, and the circumstances under which the exposure incident happened;

(b) Identification and documentation of the source individual, unless you can establish that identification is infeasible or prohibited by state or local law;

(d) Post-exposure preventive treatment, when medically indicated, as recommended by the United States Public Health Service;

(e) Counseling;

(f) Evaluation of reported illnesses.

(4) You must make sure that all laboratory tests are conducted by a laboratory licensed by the state or Clinical Laboratory Improvement Amendments Act (CLIA).

Note:

The employer or a third-party health care provider identified by the employer may do the evaluation.

[Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050. WSR 15-23-086, § 296-823-16005, filed 11/17/15, effective 12/18/15. Statutory Authority: RCW 49.17.010, 49.17.040, 49.17.050, and 49.17.060. WSR 04-12-070, § 296-823-16005, filed 6/1/04, effective 9/1/04; WSR 03-09-110, § 296-823-16005, filed 4/22/03, effective 8/1/03.]

PDFWAC 296-823-16005

Make a confidential medical evaluation and follow-up available to employees who experience an exposure incident.